Literature DB >> 23273377

Complex fractures of the distal humerus in the elderly: is primary total elbow arthroplasty a valid treatment alternative? A series of 20 cases.

G Ducrot1, M Ehlinger, P Adam, A Di Marco, P Clavert, F Bonnomet.   

Abstract

INTRODUCTION: Distal humerus fractures are fairly rare. But as our population ages, these fractures become more complex and the choice of treatment more delicate. Poor bone quality results in many technical problems and the fixation hardware stability remains at risk. The goal of this study was to evaluate the functional recovery and morbidity of complex distal humerus fractures in elderly patients when treated with elbow prosthesis. HYPOTHESIS: Good functional recovery can be achieved with a total joint replacement. PATIENTS AND METHODS: This series consisted of 20 patients (18 women and two men) having an average age of 80years (range 65-93, median 80). Based on the AO classification, there were two Type A2 fractures, two Type B fractures, 15 Type C fractures and one fracture that could not be classified because of previous rheumatoid disease history at this elbow. Two fractures were open. In two cases, the olecranon was also fractured. Treatment consisted of the implantation of a Coonrad-Morrey, hinge-type total elbow prosthesis (Zimmer(®), Warsaw, IN, USA). The Mayo Clinic surgical approach was used 17 times and the transolecranon approach was used three times. Primary arthroplasty was performed in 19 cases and the surgery was performed after six weeks of conservative treatment (diagnostic delay) in one case. Unrestricted motion was allowed after surgery, but a maximum of 0.5kg could be carried during the first 3months; this was subsequently increased to 2.5kg.
RESULTS: Fifteen of the 20 patients were available for reevaluation with an average follow-up of 3.6years (range 1.7-5.5, median 3.4). Four patients had died and one was lost to follow-up. The average range of motion was 97° (range 60-130°), comprising an average flexion of 130° (range 110-140°) and average loss of extension of 33° (range 0-80°). Pronation and supination were normal. The average Mayo Elbow Performance Score (MEPS) was 83 (range 60-100, median 80). X-rays revealed seven cases of radiolucent lines, with two being progressive. There was no visible wear of the polyethylene bushings at the hinge. Six patients had moderate periarticular heterotopic ossification. The two cases of olecranon osteotomy and one case of olecranon fracture had healed. There were no surgical site infections but two cases of ulnar compression, one of which required neurolysis. There was one case of humeral component loosening after 6years, but the implant was not changed. DISCUSSION: The clinical range of motion results were comparable to published data. The functional scores were slightly lower, mainly because of the pain factor. The initial results were encouraging and consistent with published data as long as the indications were well-chosen. Based on this retrospective study, total elbow arthroplasty can be a valid alternative in the surgeon's treatment armamentarium for complex distal humerus fractures in elderly patients who have moderate functional demands. Our results support our hypothesis, since we found good functional recovery without associated morbidity. LEVEL OF EVIDENCE: Level IV retrospective study without comparator.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273377     DOI: 10.1016/j.otsr.2012.10.010

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  14 in total

1.  Total elbow joint replacement for the treatment of distal humerus fracture of type c in eight elderly patients.

Authors:  Wei Tian; Chao He; Jian Jia
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Trends in total elbow arthroplasty: a nationwide analysis in Germany from 2005 to 2014.

Authors:  Alexander Klug; Yves Gramlich; Johannes Buckup; Uwe Schweigkofler; Reinhard Hoffmann; Kay Schmidt-Horlohé
Journal:  Int Orthop       Date:  2018-02-08       Impact factor: 3.075

Review 3.  Surgical management of osteoarthritis.

Authors:  Benedikt Proffen; Patrick Vavken; Ronald Dorotka
Journal:  Wien Med Wochenschr       Date:  2013-04-26

4.  Arthroplasty compared to internal fixation by locking plate osteosynthesis in comminuted fractures of the distal humerus.

Authors:  Alexander Ellwein; Helmut Lill; Christine Voigt; Pauline Wirtz; Gunnar Jensen; Jan Christoph Katthagen
Journal:  Int Orthop       Date:  2014-12-23       Impact factor: 3.075

5.  Complex fractures of the distal humerus in the elderly: primary total elbow arthroplasty or open reduction and internal fixation? Mid-term follow-up.

Authors:  Yaiza Lopiz; Daniel Garríguez-Pérez; Carlos García-Fernández; Laura Del Baño; María Galán-Olleros; Fernando Marco
Journal:  Int Orthop       Date:  2021-04-12       Impact factor: 3.075

Review 6.  Indications and outcome in total elbow arthroplasty: A systematic review.

Authors:  Vasileios Samdanis; Gopikanthan Manoharan; Robert W Jordan; Adam C Watts; Paul Jenkins; Rohit Kulkarni; Michael Thomas; Amar Rangan; Stuart M Hay
Journal:  Shoulder Elbow       Date:  2019-09-12

7.  Distal Humerus Fractures Managed With Elbow Hemiarthroplasty.

Authors:  J D Stephens; Brandon Kohrs; Logan Bushnell; Speros Gabriel; H Brent Bamberger
Journal:  J Shoulder Elb Arthroplast       Date:  2020-11-23

8.  A systematic review of the complications of contemporary total elbow arthroplasty.

Authors:  Phoebe Parker; Nicholas D Furness; Jonathan P Evans; Timothy Batten; William J White; Christopher D Smith
Journal:  Shoulder Elbow       Date:  2020-02-25

9.  Primary total elbow arthroplasty in complex fractures of the distal humerus.

Authors:  Brian Weng Sørensen; Stig Brorson; Bo Sanderhoff Olsen
Journal:  World J Orthop       Date:  2014-07-18

Review 10.  Fracture-pattern-related therapy concepts in distal humeral fractures.

Authors:  Rony-Orijit Dey Hazra; Helmut Lill; Gunnar Jensen; Julia Imrecke; Alexander Ellwein
Journal:  Obere Extrem       Date:  2018-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.